Company Quick10K Filing
Dynex Capital
10-Q 2020-09-30 Filed 2020-11-03
10-Q 2020-06-30 Filed 2020-08-03
10-Q 2020-03-31 Filed 2020-05-11
10-K 2019-12-31 Filed 2020-02-25
10-Q 2019-09-30 Filed 2019-11-05
10-Q 2019-06-30 Filed 2019-08-06
10-Q 2019-03-31 Filed 2019-05-03
10-K 2018-12-31 Filed 2019-02-27
10-Q 2018-09-30 Filed 2018-11-06
10-Q 2018-06-30 Filed 2018-08-07
10-Q 2018-03-31 Filed 2018-05-08
10-K 2017-12-31 Filed 2018-03-05
10-Q 2017-09-30 Filed 2017-11-03
10-Q 2017-06-30 Filed 2017-08-08
10-Q 2017-03-31 Filed 2017-05-10
10-K 2016-12-31 Filed 2017-03-15
10-Q 2016-09-30 Filed 2016-11-07
10-Q 2016-06-30 Filed 2016-08-05
10-Q 2016-03-31 Filed 2016-05-09
10-K 2015-12-31 Filed 2016-03-08
10-Q 2015-09-30 Filed 2015-11-05
10-Q 2015-06-30 Filed 2015-08-10
10-Q 2015-03-31 Filed 2015-05-11
10-K 2014-12-31 Filed 2015-03-12
10-Q 2014-09-30 Filed 2014-11-10
10-Q 2014-06-30 Filed 2014-08-11
10-Q 2014-03-31 Filed 2014-05-12
10-K 2013-12-31 Filed 2014-03-04
10-Q 2013-09-30 Filed 2013-11-12
10-Q 2013-06-30 Filed 2013-08-09
10-Q 2013-03-31 Filed 2013-05-10
10-K 2012-12-31 Filed 2013-03-08
10-Q 2012-09-30 Filed 2012-11-08
10-Q 2012-03-31 Filed 2012-05-10
10-K 2011-12-31 Filed 2012-03-02
10-Q 2011-09-30 Filed 2011-11-09
10-Q 2011-06-30 Filed 2011-08-05
10-Q 2011-03-31 Filed 2011-05-10
10-K 2010-12-31 Filed 2011-03-16
10-Q 2010-09-30 Filed 2010-11-09
10-Q 2010-06-30 Filed 2010-08-09
10-Q 2010-03-31 Filed 2010-05-10
10-K 2009-12-31 Filed 2010-03-08
8-K 2021-02-04
8-K 2021-01-28
8-K 2021-01-28
8-K 2021-01-15
8-K 2020-12-18
8-K 2020-10-28
8-K 2020-10-13
8-K 2020-09-23
8-K 2020-08-28
8-K 2020-08-07
8-K 2020-08-04
8-K 2020-07-29
8-K 2020-06-09
8-K 2020-05-06
8-K 2020-04-27
8-K 2020-04-15
8-K 2020-03-19
8-K 2020-03-13
8-K 2020-02-27
8-K 2020-02-13
8-K 2020-02-06
8-K 2019-11-13
8-K 2019-10-31
8-K 2019-07-31
8-K 2019-06-20
8-K 2019-06-11
8-K 2019-05-31
8-K 2019-05-10
8-K 2019-05-01
8-K 2019-02-07
8-K 2019-01-28
8-K 2019-01-28
8-K 2019-01-01
8-K 2018-12-11
8-K 2018-10-31
8-K 2018-09-04
8-K 2018-08-02
8-K 2018-06-29
8-K 2018-05-15
8-K 2018-05-02
8-K 2018-03-12
8-K 2018-02-21

Dynex Capital Financials

DX Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Aries I Acquisition Corp. (RAMMU)
024 Pharma (EEIG)
Beauty Health Co (VSPRW)
Aquarius I Acquisition Corp. (AQUI)
MIZUHO FINANCIAL GROUP INC (MZHOF)
Eucrates Biomedical Acquisition Corp. (EUCRW)
11 Good Energy (ELVN)
180 Life Sciences Corp. (ATNFW)
1347 Capital Corp (TFSC)
Avanti Acquisition Corp. (AVAN-WT)
CORDIA CORP (CORG)
FCCC INC (FCIC)
Biofrontera Inc. (BFRI)
Ameren Illinois Co (AILNP)
MITSUBISHI UFJ FINANCIAL GROUP INC (MBFJF)
Janus International Group, Inc. (JBI-WT)
23andMe Holding Co. (MEUSW)
OceanTech Acquisitions I Corp. (OTECU)
Palayan Resources, Inc. (PLYN)
ALABAMA POWER CO (APRCP)

Balance Sheet ($MM)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash341049425435564429406961375744675878518797857466101162878621811489143111139
Accounts Receivable
Inventory
PP&E
Assets2,6572,6342,5823,3493,7294,4054,2804,6284,7494,3204,2174,1444,1163,8143,6884,0764,1693,9283,6703,5843,4693,3443,3983,3403,0603,1433,3063,2063,0833,4483,8865,0355,8695,487
Accounts Payable
Long-Term Debt10684713213998887666
Liabilities2,2702,2642,2112,8263,2043,7873,6643,9954,1423,7393,6313,5453,5033,1993,0813,4703,5943,4003,1783,1002,9782,8492,9312,8472,5632,6192,7492,6622,5412,9013,3594,4305,2704,903
Stockholders' Equity387370371523525618617633607581
Income Statement ($MM)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue
Cost of Revenue
Gross Profit
R&D
SG&A4443
Tax
Net Income14214163419202032-522-1-6314-930-3733-37-315699-71022441626-52-119-37
Cash Flow ($MM)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating2017243438534557565150565455515754545453515347565348425146404537
Cash Investing4729-697-432-65694-187-4703959760-1328195-187-3501631651719361-25734276-26-195-78188-326-1,007-640-33
Cash Financing-91-8666410599-126130399-440-118-118-67-316-163131311-261-198-175-132-136205-89-29797335-1071761,02156423